EUVIMEDEUVIMED entdecken
Crossref

Spatial intratumor heterogeneity of programmed death-ligand 1 expression predicts poor prognosis in resected non–small cell lung cancer

Yusuke Nagasaki, Tetsuro Taki iD, Kotaro Nomura, Kenta Tane, Tomohiro Miyoshi iD, Joji Samejima iD, Keiju Aokage, Seiyu Jeong-Yoo Ohtani-Kim, Motohiro Kojima, Shingo Sakashita, Naoya Sakamoto, Shumpei Ishikawa und 3 weitere

JNCI: Journal of the National Cancer Institute · 2024

DOI: 10.1093/jnci/djae053 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2024. Verfasst von Yusuke Nagasaki und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Chiba, Japan. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, B7-H1 Antigen, Lung Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We quantified the pathological spatial intratumor heterogeneity of programmed death-ligand 1 (PD-L1) expression and investigated its relevance to patient outcomes in surgically resected non–small cell lung carcinoma (NSCLC).

Methods

This study enrolled 239 consecutive surgically resected NSCLC specimens of pathological stage IIA-IIIB. To characterize the spatial intratumor heterogeneity of PD-L1 expression in NSCLC tissues, we developed a mathematical model based on texture image analysis and determined the spatial heterogeneity index of PD-L1 for each tumor. The correlation between the spatial heterogeneity index of PD-L1 values and clinicopathological characteristics, including prognosis, was analyzed. Furthermore, an independent cohort of 70 cases was analyzed for model validation.

Results

Clinicopathological analysis showed correlations between high spatial heterogeneity index of PD-L1 values and histological subtype (squamous cell carcinoma; P < .001) and vascular invasion (P = .004). Survival analysis revealed that patients with high spatial heterogeneity index of PD-L1 values presented a significantly worse recurrence-free rate than those with low spatial heterogeneity index of PD-L1 values (5-year recurrence-free survival [RFS] = 26.3% vs 47.1%, P < .005). The impact of spatial heterogeneity index of PD-L1 on cancer survival rates was verified through validation in an independent cohort. Additionally, high spatial heterogeneity index of PD-L1 values were associated with tumor recurrence in squamous cell carcinoma (5-year RFS = 29.2% vs 52.8%, P < .05) and adenocarcinoma (5-year RFS = 19.6% vs 43.0%, P < .01). Moreover, we demonstrated that a high spatial heterogeneity index of PD-L1 value was an independent risk factor for tumor recurrence.

Conclusions

We presented an image analysis model to quantify the spatial intratumor heterogeneity of protein expression in tumor tissues. This model demonstrated that the spatial intratumor heterogeneity of PD-L1 expression in surgically resected NSCLC predicts poor patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungB7-H1 AntigenLung NeoplasmsHumansMaleFemalePrognosisMiddle AgedAgedBiomarkers, TumorNeoplasm Recurrence, LocalNeoplasm StagingAdultCarcinoma, Squamous Cell

Substanzen

B7-H1 AntigenCD274 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
  • Department of Thoracic Surgery, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
  • Department of General Thoracic Surgery, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Division of Pathology, National Cancer Center, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
  • Department of Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Division of Innovative Pathology and Laboratory Medicine, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.

ORCID-Profile: Tetsuro Taki, Tomohiro Miyoshi, Joji Samejima, Kenji Suzuki

Förderung

  • Japan Society for the Promotion of Science
  • KAKENHI

Zitieren

APA

Nagasaki, Y., Taki, T., Nomura, K., Tane, K., Miyoshi, T., Samejima, J., Aokage, K., Ohtani-Kim, S. J., Kojima, M., Sakashita, S., Sakamoto, N., Ishikawa, S., Suzuki, K., Tsuboi, M., & Ishii, G. (2024). Spatial intratumor heterogeneity of programmed death-ligand 1 expression predicts poor prognosis in resected non–small cell lung cancer. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djae053

Vancouver

Nagasaki Y, Taki T, Nomura K, Tane K, Miyoshi T, Samejima J, et al. Spatial intratumor heterogeneity of programmed death-ligand 1 expression predicts poor prognosis in resected non–small cell lung cancer. JNCI: Journal of the National Cancer Institute. 2024. doi:10.1093/jnci/djae053

BibTeX
@article{Nagasaki2024,
  author = {Nagasaki, Yusuke and Taki, Tetsuro and Nomura, Kotaro and Tane, Kenta and Miyoshi, Tomohiro and Samejima, Joji and Aokage, Keiju and Ohtani-Kim, Seiyu Jeong-Yoo and Kojima, Motohiro and Sakashita, Shingo and Sakamoto, Naoya and Ishikawa, Shumpei and Suzuki, Kenji and Tsuboi, Masahiro and Ishii, Genichiro},
  title = {Spatial intratumor heterogeneity of programmed death-ligand 1 expression predicts poor prognosis in resected non–small cell lung cancer},
  journal = {JNCI: Journal of the National Cancer Institute},
  year = {2024},
  doi = {10.1093/jnci/djae053}
}
Kostenlos starten →